Health & bio
GLP-1 Indication Expansion: Atrial Fibrillation, Alcohol Disorder, Depression, Diabetic Retinopathy
April clinical data releases documented efficacy beyond obesity across four additional therapeutic domains, initiating multi-indication era.
Primary sources · 1